Clinical Context of the Consensus: A Review of the Latest Recommendations for Waldenström Macroglobulinemia

Did you know that the latest guidelines for Waldenström macroglobulinemia now encompass second-generation Bruton tyrosine kinase inhibitors? Credit available for this activity expires: 10/16/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997311?ecd=bdc_podcast_libsyn_mscpedu